NOM-034-SSA2-2002, para la prevención y control de los defectos ...
NOM-034-SSA2-2002, para la prevención y control de los defectos ...
NOM-034-SSA2-2002, para la prevención y control de los defectos ...
Create successful ePaper yourself
Turn your PDF publications into a flip-book with our unique Google optimized e-Paper software.
13.63 Mudd SH, Skovby F, Levy HL, et al. The natural history of homocystinuria due tocystathionine -syntethase <strong>de</strong>ficiency. Am J Hum Genet 1985; 37:1-31.13.64 Na<strong>de</strong>au F, McKinna J, Sater L, et al. Newborn screening for cystic fibrosis.Standardization document. Preliminary Draft 1996. US Department of Health & HumanServices. At<strong>la</strong>nta, GA.13.65 Nova JJ, Nova AH. Maternal Transmission of Congenital heart disease. Am J Cardiol1987; 59:459-463.13.66 Ordoñez-Sánchez ML, Ramírez-Jiménez S, López-Gutiérrez AU, et al. Molecu<strong>la</strong>r geneticanalysis of patients carryng steroid 21-hydroxy<strong>la</strong>se <strong>de</strong>ficiency in the Mexican popu<strong>la</strong>tion:I<strong>de</strong>ntifications of passible new mutations and high prevalence of apparent germ-line mutations.Hum Genet 1998; 102:170-177.13.67 Palmer C, Vannucci RC. Potential new therapies for perinatal cerebral hypoxia-ischemia(Review). Clin Perinatol 1993; 20:411-432.13.68 Pol<strong>la</strong>ck RN, Divon MY. Intrauterine growth retardation: <strong>de</strong>finition, c<strong>la</strong>ssification, an<strong>de</strong>tiology, Clin Obstet Gynecol 1992; 35:99-103.13.69 Reiner W. Sex assignment in the neonate with intersex or ina<strong>de</strong>quate genitalia. ArchPediatr Adolesc Med 1997; 151:1044-1045.13.70 Robert E, Gui<strong>la</strong>nd P. Maternal valproic acid and congenital neural tube <strong>de</strong>fects. Lancet1982; 2:934.13.71 Rose FW. Spina bifida in infants of woman treated with carbamazepine during pregnancy.N Engl J Med 1991; 324:674.13.72 Rose NC, Mennuti MT. Periconceptional folic acid supplementation as a socialintervention. Sem in Perinatology 1995; 19:243-254.13.73 Sarnat HB, Sarnat MS. Neonatal encephalopathy following fetal distress: A clinical an<strong>de</strong>lectroencephalographic study. Arch Neurol 1976; 33:696-705.13.74 Schwartz R, Díaz GA, Fescina R, et al. Atención prenatal y <strong>de</strong>l parto <strong>de</strong> bajo riesgo.Centro Latinoamericano <strong>de</strong> Perinatología y Desarrollo Humano. Pub. Científica No. 1205.Uruguay, 1990.13.75 Shankaran S. Perinatal asphyxia. Clin Perinatol 1993; 20:287-291.13.76 Shimozawa K, Saisho S, Saito N, et al. A neonatal mass-screening for congenital adrenalhyperp<strong>la</strong>sia in Japan. Acta Endocrinol 1984; 107:513-518.13.77 Sny<strong>de</strong>rman SE, Sansaricq C. Newborn screening for maple syrup urine disease. JPediatr 1985; 107:259-261.13.78 Spranger J, Benirschke K, Hall JG, et al. Errors of morphogenesis: Concepts and terms.Recommendation of an international working group. J. Pediatr 1982; 100:160-164.13.79 Soothill PW, Ajayi RA, Nico<strong>la</strong>i<strong>de</strong>s KN. Fetal biochemistry in growth retardation, Early HumDev 1992; 29:91-95.13.80 Tsang RC. Nutritional needs of the premature infant: Scientific Basis and PracticalGui<strong>de</strong>lines. Baltimore: Williams and Wilkins, 1993.
Change language